Do amiodarone or Macrobid (nitrofurantoin) cause a sun-related rash?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amiodarone and Nitrofurantoin (Macrobid) Sun-Related Rash Risk

Yes, amiodarone causes sun-related rashes in >50% of patients, while there is no evidence that nitrofurantoin (Macrobid) causes photosensitivity reactions. 1, 2

Amiodarone-Induced Photosensitivity

Mechanism and Presentation

  • Amiodarone is a well-documented photosensitizer that causes photosensitivity reactions in more than 50% of treated patients 1
  • The typical presentation includes:
    • Burning and tingling sensation in sun-exposed skin
    • Associated erythema (redness)
    • Develops shortly after sun exposure 3
    • Primarily activated by long-wave UV-A spectrum (350-380 nm) 3

Severity and Timeline

  • Photosensitivity typically develops after approximately 4 months of continuous treatment 4
  • Requires a minimum cumulative dose of approximately 40g 4
  • Can persist for months to years after discontinuation of the medication 5
    • In rare cases, photosensitivity can persist for over 17 years after discontinuation 5

Long-term Effects

  • With prolonged use and sun exposure, amiodarone induces a distinctive blue-grey pigmentation on sun-exposed sites in 1-2% of patients 1
  • This hyperpigmentation typically develops after:
    • An average of 20 months of continuous treatment
    • A minimum total dose of 160g 4
  • Hyperpigmentation is generally reversible after drug discontinuation, though resolution may take many months 4

Prevention and Management

Sun Protection Measures

  • Patients taking amiodarone should be advised to:
    • Seek shade when outside, particularly around midday 1
    • Wear protective clothing covering as much of the body as possible
    • Use broad-brimmed hats and sunglasses
    • Apply broad-spectrum sunscreens with SPF 30 or higher 1, 2
    • Consider sunscreens containing dioxybenzone, which has been shown to reduce phototest reactions 3

Monitoring and Follow-up

  • Regular skin examinations should be included in routine follow-up 2
  • Patients should be counseled about photosensitivity risk before starting amiodarone
  • If severe photosensitivity occurs, consider:
    • Dose reduction if clinically feasible
    • Alternative anti-arrhythmic agents if the patient's cardiac condition allows

Clinical Pearls and Pitfalls

  • Photosensitivity appears to be a phototoxic reaction rather than photoallergic, as it occurs in nearly all patients receiving sufficient doses 3
  • The risk is unrelated to skin type, though hyperpigmentation is more common in patients with skin type I 4
  • Photosensitivity can occur even with brief sun exposure and may be exacerbated by factors such as altitude, reflective surfaces (water, snow, sand), and time of day 1
  • Unlike many photosensitizing drugs that primarily react to UVB, amiodarone photosensitivity is primarily triggered by UVA wavelengths 3

In summary, amiodarone carries a significant risk of photosensitivity reactions, while nitrofurantoin (Macrobid) is not associated with sun-related rashes based on the available evidence.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amiodarone Therapy Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Amiodarone photosensitivity.

Archives of dermatology, 1984

Research

Persistent severe amiodarone-induced photosensitivity.

Clinical and experimental dermatology, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.